Earnings History Data for Cytek Biosciences, Inc. (CTKB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cytek Biosciences, Inc.
Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
05-11-2024 | AH | CTKB | Cytek Biosciences, Inc. | 650.30 | 0.01 | -0.03 | -0.03 | Cytek Biosciences GAAP EPS of $0.01 beats by $0.02, revenue of $51.5M beats by $0.8M [11/5/2024 4:17 PM] |
7.38 | 1.93 (35.57%) |
5.88 | 0.44 (8.09%) |
3.80 - 9.87 | 3,900,092 | 560,000 | 31,373 | ||
|
||||||||||||||||||
06-08-2024 | AH | CTKB | Cytek Biosciences, Inc. | 841.46 | -0.08 | -0.03 | -0.02 | Cytek Biosciences GAAP EPS of -$0.08 misses by $0.05, revenue of $46.62M misses by $2.91M [8/6/2024 5:21 PM] |
5.08 | -0.54 (-9.52%) |
6.50 | 0.88 (15.65%) |
3.80 - 9.87 | 1,903,178 | 540,000 | 20,262 | ||
08-05-2024 | AH | CTKB | Cytek Biosciences, Inc. | 839.89 | -0.05 | -0.04 | -0.03 | Cytek Biosciences GAAP EPS of -$0.05, revenue of $44.9M [5/8/2024 5:57 PM] |
6.20 | -0.07 (-1.12%) |
6.50 | 0.23 (3.67%) |
3.80 - 11.70 | 619,356 | 600,000 | 17,573 | ||
28-02-2024 | AH | CTKB | Cytek Biosciences | 1,182 | N/A | 0.02 | 0.00 | Cytek Biosciences reports Q4 results [2/28/2024 5:10 PM] |
7.71 | -1.03 (-11.73%) |
8.74 | 0.0 (0.00%) |
3.80 - 12.31 | 1,205,786 | 520,000 | 32,093 | ||
07-11-2023 | AH | CTKB | Cytek Biosciences, Inc. | 598.62 | -0.03 | -0.01 | 0.01 | Cytek Biosciences GAAP EPS of -$0.05 misses by $0.08, revenue of $48M misses by $7.48M [11/7/2023 4:45 PM] |
4.99 | 0.54 (12.13%) |
3.80 | -0.65 (-14.61%) |
3.80 - 15.17 | 946,785 | 1,290,000 | 4,960 | ||
08-08-2023 | AH | CTKB | Cytek Biosciences, Inc. | 1,230 | -0.02 | 0.00 | 0.00 | Cytek Biosciences GAAP EPS of -$0.03 misses by $0.02, revenue of $49.69M beats by $3.98M [8/8/2023 4:53 PM] |
8.98 | 0.06 (0.73%) |
8.92 | 0.0 (0.00%) |
6.45 - 16.05 | 653,374 | 700,000 | 13,315 | ||
09-05-2023 | AH | 4:05 PM ET (May 9) |
CTKB | Cytek Biosciences, Inc. | 1,610 | -0.03 | 0.00 | -0.02 | Cytek Biosciences GAAP EPS of -$0.05 misses by $0.06, revenue of $37.1M misses by $10.05M [5/9/2023 5:16 PM] |
8.86 | -2.81 (-24.12%) |
10.95 | -0.72 (-6.17%) |
7.38 - 16.05 | 5,459,677 | 3,450,000 | 30,684 | |
28-02-2023 | AH | 4:05 PM ET (Feb 28) |
CTKB | Cytek Biosciences, Inc. | 1,520 | 0.03 | 0.01 | 0.05 | Cytek Biosciences GAAP EPS of $0.02, revenue of $164.04M [2/28/2023 4:54 PM] |
9.48 | -0.82 (-7.91%) |
10.30 | 0.0 (0.00%) |
7.38 - 16.05 | 714,260 | 600,000 | 67,457 | |
09-11-2022 | AH | 4:05 PM ET (Nov 9) |
CTKB | Cytek Biosciences, Inc. | 1,980 | 0.01 | 0.02 | 0.00 | Cytek Biosciences reports mixed Q3 earnings; reaffirms FY22 guidance [11/9/2022 5:07 PM] |
14.43 | 0.73 (5.33%) |
13.70 | 0.0 (0.00%) |
7.38 - 24.65 | 868,081 | 480,000 | 17,790 | |
10-08-2022 | AH | 4:05 PM ET (Aug 10) |
CTKB | Cytek Biosciences, Inc. | 1,610 | N/A | 0.02 | 0.00 | Cytek Biosciences Non-GAAP EPS of $0.03, revenue of $40.2M [8/10/2022 4:34 PM] |
14.82 | -0.63 (-4.08%) |
15.48 | 0.03 (0.19%) |
7.38 - 28.70 | 553,147 | 490,000 | 26,092 | |
11-05-2022 | AH | 4:05 PM ET (May 11) |
CTKB | Cytek Biosciences, Inc. | 1,050 | -0.02 | 0.00 | 0.00 | Cytek Biosciences Non-GAAP EPS of $0.01 misses by $0.01, revenue of $35.1M beats by $2.1M [5/11/2022 4:50 PM] |
8.14 | 0.73 (9.85%) |
7.41 | 0.0 (0.00%) |
7.38 - 28.70 | 644,616 | 620,000 | 4,180 | |
23-02-2022 | AH | 4:05 PM ET (Feb 23) |
CTKB | Cytek Biosciences, Inc. | 1,860 | 0.05 | 0.02 | 0.00 | Cytek Biosciences Non-GAAP EPS of $0.09 misses by $0.02, revenue of $127.95M beats by $2.53M [2/23/2022 5:24 PM] |
12.79 | -0.33 (-2.52%) |
13.12 | 0.0 (0.00%) |
0.0 - 0.0 | 617,431 | 0 | 1,825 | |
08-11-2021 | AH | 4:00 PM ET (Nov 8) |
CTKB | Cytek Biosciences, Inc. | 3,250 | N/A | 0.02 | 0.00 | Cytek Biosciences beats on revenue [11/8/2021 4:10 PM] |
24.53 | -0.51 (-2.04%) |
24.71 | 0.0 (0.00%) |
17.40 - 28.70 | 157,509 | 130,000 | 1,061 | |